Company intelligence / Profile preview

EndoBar Solutions

Orangeburg, New York, United Stateskoin.com ↗

Ownership: Private
Development stage: Preclinical

Overview

EndoBar Solutions has developed the Lamina™ robotic embolization system, which enables safe, controlled, and targeted transcatheter delivery of concentrated therapies—primarily for bariatric embolotherapy and oncology-related procedures. Clinical studies supported by the company have shown that transcatheter bariatric embolotherapy can achieve significant weight loss in obese patients with a favorable safety profile; however, larger trials are needed to confirm efficacy and safety.

Therapeutic areas: OncologyEndocrinology
Modalities: DeviceEmbolotherapy system (for targeted drug delivery)
Industry: Surgical Medical Devices

Partnerships

Hatch Medical L.L.C. was retained to broker strategic transactions for commercialization or licensing of the technology.

Beyond the preview

Go deeper on EndoBar Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EndoBar Solutions.

Explore the full profile